2017
DOI: 10.1097/jcp.0000000000000791
|View full text |Cite
|
Sign up to set email alerts
|

Cannabinoid Hyperemesis Syndrome (CHS)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
1

Year Published

2018
2018
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 10 publications
0
3
0
1
Order By: Relevance
“…Our review of the literature identified a total of 25 case series (n = 271) and 105 individual case reports of patients identified with CHS (Table ) . Most of the reported case series and case studies predated the publication of Rome IV criteria for CHS.…”
Section: Resultsmentioning
confidence: 99%
“…Our review of the literature identified a total of 25 case series (n = 271) and 105 individual case reports of patients identified with CHS (Table ) . Most of the reported case series and case studies predated the publication of Rome IV criteria for CHS.…”
Section: Resultsmentioning
confidence: 99%
“…Marillier et al (2017) de 19 pacientes, 12 haviam perdido 5 kg ou mais. 6,38 Embora as complicações cardíacas não pareçam comuns nos quadros de SHC, alguns autores verificaram ocorrência de eventos cardíacos associados. Existe descrição de pelo menos um caso de enfarte agudo do miocárdio, por vasoespasmo, em contexto de SHC.…”
Section: Complicaçõesunclassified
“…What I find most disturbing about the MJ information available to the public is the relative absence of information about its deleterious and sometimes paradoxical effects. Here are two examples that have not received meaningful coverage in the lay press or in Internet news feeds: (1) I have seen three patients successfully treated for panic disorder with cognitiveÀbehavioral therapy (CBT) who had severe panic attacks when they smoked MJ-many advertisements for MJ and other cannabinoids claim that MJ helps with anxiety-the NAS report notes that there is moderate statistical support for MJ to be associated with an increased incidence of social anxiety disorder and limited evidence for a link with increased symptoms of anxiety; and (2) in France, 99 cases of cannabinoid hyperemesis syndrome (CHS) in daily MJ users had been reported 42 -CHS was first reported in Australia 43 and is infrequently reported in the United States-by contrast, the NAS report concludes that there is substantial evidence for the effectiveness of MJ or cannabinoids as anti-nauseates. Despite its anti-nausea effects, women should not use MJ to treat first-trimester nausea (hyperemesis gravidarum) due to the potential for adverse effects on the developing fetal brain.…”
Section: Marijuana and Underreported Risksmentioning
confidence: 99%